Enhanced External Counterpulsation in Patients With Heart Failure: A Multicenter Feasibility Study

Ozlem Soran, MD, Bruce Fleishman, MD, Theresa Demarco, MD, William Grossman, MD, Virginia M. Schneider, RN, Karen Manzo, RN, Paul-André de Lame, MD, Arthur M. Feldman, MD, PhD

Disclosures

CHF. 2002;8(4) 

In This Article

Conclusions

EECP appears safe when applied as adjunct therapy for heart failure. The efficacy results of this study must be viewed with care, as the size of the study population was small and comparisons were not made with a control group. However, the salutary effects of EECP on functional capacity in the absence of adverse events are intriguing. The efficacy results suggest that EECP can improve exercise capacity, quality of life and functional status, both in the short term and also for a period of 6 months after completion of the EECP therapy.

Importantly, the results of this feasibility study warrant the initiation of a randomized controlled study to ascertain the efficacy of EECP as an adjunctive therapy in the management of patients with chronic stable heart failure.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....